CRISPR/Cas9 technology: applications in oocytes and early embryos

Area of Science:

• Reproductive Biology
• Genetics
• Molecular Biology

Background:

• CRISPR/Cas9 is a versatile genome-editing technology.
• Its application in mammalian oocytes and early embryos is expanding.
• Oocytes and early embryos possess unique cellular characteristics.

Purpose of the Study:

• To review CRISPR/Cas9 methodologies and applications in oocyte and early embryo development.
• To explore its use in understanding developmental intricacies and associated diseases.
• To discuss limitations and ethical considerations of CRISPR/Cas9 in reproductive contexts.

Main Methods:

• Comprehensive literature review of CRISPR/Cas9 applications in mammalian reproduction.
• Analysis of fundamental principles and methodologies.
• Evaluation of current and potential future applications.

Main Results:

• CRISPR/Cas9 enables detailed study of molecular events in oocyte and embryo development.
• The technology shows promise for addressing diseases related to early development.
• Potential for genome and epigenome manipulation in these critical cell types.

Conclusions:

• CRISPR/Cas9 is a powerful tool for advancing reproductive biology research.
• Acknowledging and addressing off-target effects and ethical concerns is crucial.
• Ongoing technological refinements will enhance future applications in mammalian reproduction.